Pathstone Holdings’s LeMaitre Vascular LMAT Stock Holding History

Pathstone Holdings’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Sell	3,831 -86	-2%	-$8.2K	﹤0.01%	1829
2025 Q4	$318K	Sell	3,917 -8	-0.2%	-$689	﹤0.01%	1937
2025 Q3	$344K	Buy	3,925 +344	+10%	+$30.7K	﹤0.01%	1966
2025 Q2	$297K	Sell	3,581 -1,179	-25%	-$98.5K	﹤0.01%	1928
2025 Q1	$400K	Buy	4,760 +61	+1%	+$5.67K	﹤0.01%	1815
2024 Q4	$433K	Sell	4,699 -277	-6%	-$26.6K	﹤0.01%	1789
2024 Q3	$462K	Buy	4,976 +24	+0.5%	+$2.08K	﹤0.01%	1765
2024 Q2	$407K	Buy	4,952 +8	+0.2%	+$588	﹤0.01%	1796
2024 Q1	$328K	Sell	4,944 -327	-6%	-$20.2K	﹤0.01%	1891
2023 Q4	$299K	Buy	+5,271	New	+$276K	﹤0.01%	1829

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Pathstone Holdings's LMAT Position: Q1 2026 in Review

Pathstone Holdings reduced its LeMaitre Vascular (LMAT) stake by 2.2% in Q1 2026, selling an estimated $8.2K and leaving 3,831 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Pathstone Holdings first reported a position in LMAT in Q4 2023 and has held it in 10 quarters since. The position peaked at $462K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Pathstone Holdings held 3,831 shares of LeMaitre Vascular worth $418K as of Q1 2026.
Pathstone Holdings sold 86 LeMaitre Vascular shares in Q1 2026, an estimated $8.2K.
LeMaitre Vascular made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #1829 holding.
Pathstone Holdings first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 10 quarters since.
Pathstone Holdings's LeMaitre Vascular position peaked at $462K in Q3 2024.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.